Adjunctive Nephrectomy at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer-Reference-Cited by-同舟云学术

Adjunctive Nephrectomy at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer

Published:2006-11 Issue:5 Volume:176 Page:1996-1999
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Stephenson Andrew J.¹,Tal Raanan¹,Sheinfeld Joel¹

Affiliation:

1. Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference16 articles.

1. a prognostic factor-based staging system for metastatic germ cell cancers;J Clin Oncol,1997

2. Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer;Beck;J Urol,2002

3. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses;Oldenburg;J Clin Oncol,2003

4. Histology of good risk non-seminomatous germ cell tumor (NSGCT) patients following retroperitoneal lymph node dissection (PC-RPLND) after four cycles of etoposide and cisplatin (EPX4);Patel;J Urol,2003

5. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection;Toner;J Clin Oncol,1990

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival outcomes of postchemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: A retrospective cohort study from a single tertiary center in South India;Indian Journal of Urology;2024-04

2. Contemporary Perioperative Outcomes of Open Retroperitoneal Lymph Node Dissection for Testicular Cancer;JU Open Plus;2024-02-29

3. Retroperitoneal Lymph Node Dissection;A Guide to Management of Urological Cancers;2023

4. Testis Cancer;Holland‐Frei Cancer Medicine;2022-10-21

5. Improving outcomes in germ cell cancers using miRNA;Therapeutic Advances in Medical Oncology;2021-01